Patient controlled analgesia
Showing 1 - 25 of >10,000
Nephrolithiasis, Percutaneous, Analgesia Trial in Van (ESP, Erector Spina Plane Block)
Completed
- Nephrolithiasis
- +3 more
- ESP, Erector Spina Plane Block
-
Van, Tusba, TurkeyVan Yüzüncü Yıl University, Faculty of Medicine
May 5, 2023
Uniportal Video-assisted Thoracic Surgery Trial (Ultrasound-guided paraspinal block and patient-controlled intravenous analgesia
Not yet recruiting
- Uniportal Video-assisted Thoracic Surgery
- Ultrasound-guided paraspinal block and patient-controlled intravenous analgesia pump
- +2 more
- (no location specified)
Aug 28, 2023
Patient-controlled Analgesia Trial in Shanghai (Dezocine, Sufentanil injection, Flurbiprofen)
Completed
- Patient-controlled Analgesia
- Dezocine
- +3 more
-
Shanghai, Shanghai, ChinaFudan University
Aug 12, 2023
Caudal Analgesia & Anticoagulated Patient
Recruiting
- Lumbar Pain Syndrome
- Anticoagulants and Bleeding Disorders
- Caudal analgesia
-
Surrey, British Columbia, CanadaSalem Anaesthesia Pain Clinic
Jul 13, 2023
Postoperative Pain Trial in Istanbul (Quadratus Lumborum Block II, Patient controlled intravenous analgesia, Quadratus Lumborum
Recruiting
- Postoperative Pain
- Quadratus Lumborum Block II
- +3 more
-
Istanbul, TurkeyGaziosmanpasa Resarch and Education Hospital
Jul 5, 2023
Contraception Trial run by the Uniformed Services University of the Health Sciences (Lidocaine topical, Tampon)
Not yet recruiting
- Contraception
- Lidocaine topical
- Tampon
-
Bethesda, MarylandUniversity Family Health Center, USUHS
May 25, 2023
Oxidative Stress in Peroperative Analgesia by Intravenous
Recruiting
- Oxidative Stress
- Analgesia
- Blood sample
-
Tours, FranceUniversity hospital
Dec 29, 2022
Analgesia, Patient-Controlled, Dexmedetomidine Trial (Dexmedetomidine, Control)
Not yet recruiting
- Analgesia, Patient-Controlled
- Dexmedetomidine
- (no location specified)
Jan 5, 2023
Sickle Cell Disease, Vaso-occlusive Pain Episode in Sickle Cell Disease Trial in Bruxelles (Clonidine)
Recruiting
- Sickle Cell Disease
- Vaso-occlusive Pain Episode in Sickle Cell Disease
-
Bruxelles, BelgiumCHU Saint-Pierre
May 5, 2023
Rectus Abdominis and External Oblique Muscle Infiltration Analgesia Trial in Fuzhou (rectus abdominis(RAM) and external oblique
Completed
- Rectus Abdominis and External Oblique Muscle Infiltration Analgesia
- rectus abdominis(RAM) and external oblique muscle(EOM) infiltration analgesia
- intravenous patient-controlled anesthesia
-
Fuzhou, Fujian, ChinaThe First Affiliated Hospital of Fujian Medical University
Nov 3, 2023
Liver Cancer, Pain Management Trial in Basking Ridge, Commack, New York (IV PCA, PCEA)
Active, not recruiting
- Liver Cancer
- Pain Management
- IV PCA
- PCEA
-
Basking Ridge, New Jersey
- +2 more
Sep 13, 2022
Postoperative Pain, Acute Trial in Gyeonggi-do (Fentanyl, ketorolac tromethamine with nefopam HCl)
Recruiting
- Postoperative Pain, Acute
- Fentanyl
- ketorolac tromethamine with nefopam hydrochloride
-
Gyeonggi-do, Gwangmyeon-si, Korea, Republic ofChungAng University Gwangmyeong Hospital
May 18, 2023
Intraoperative Analgesia Trial in Athens (Nociception level index (NOL™), Fentanyl)
Recruiting
- Intraoperative Analgesia
- Nociception level index (NOL™)
- Fentanyl
-
Athens, Attiki, Greece2nd Department of Anesthesiology, Attikon University Hospital
Oct 25, 2023
Gastrointestinal Surgery Trial in XIan (sufentanil + nalbuphine, Sufentanil, hydromorphone + nalbuphine)
Completed
- Gastrointestinal Surgery
- sufentanil + nalbuphine
- +2 more
-
XIan, Shanxi, ChinaYANLI
Oct 11, 2022
Analgesia, Patient-Controlled, Brachial Plexus Block, Arthroscopic Rotator Cuff Repair Trial in Seongnam-si (CISB with IV PCA
Recruiting
- Analgesia, Patient-Controlled
- +2 more
- CISB with IV PCA group
- CISB group
-
Seongnam-si, Gyeonggi-do, Korea, Republic ofSeoul national univercity Bundang Hospital
Jan 31, 2023
Multiple Fracture Ribs Trial (amixture 0.125% bupivicaine with fentanyl, 100 ml volume containing 80 mg of nalbuphine ,180 mg
Not yet recruiting
- Multiple Fracture Ribs
- amixture 0.125% bupivicaine with fentanyl
- 100 ml volume containing 80 mg of nalbuphine ,180 mg ketorolac, 24mg dexamethasone, 16 mg danset
- (no location specified)
Jul 27, 2023
Esophageal Cancer, Perioperative Analgesia, NSAIDs Trial in Beijing (Preemptive flurbiprofen axetil, Postoperative flurbiprofen
Not yet recruiting
- Esophageal Cancer
- +4 more
- Preemptive flurbiprofen axetil
- +2 more
-
Beijing, ChinaCancer Hospital Chinese Academy of Medical Sciences
Aug 15, 2022
Breakthrough Pain Trial in Singapore (epidural delivery system, Ropivacaine, Fentanyl)
Active, not recruiting
- Breakthrough Pain
- epidural delivery system
- +2 more
-
Singapore, SingaporeKK Women's and Children's Hospital
Aug 17, 2022
Use of Patient-Controlled Analgesia in Acute Pancreatitis
Recruiting
- Acute Pancreatitis
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Jul 19, 2022
Pain, Respiratory Depression Trial in Singapore (VPIA pump, Morphine)
Active, not recruiting
- Pain
- Respiratory Depression
- VPIA pump
- Morphine
-
Singapore, SingaporeKK Women's and Children's Hospital
Aug 17, 2022
Obesity, Analgesia, Postoperative Pain Trial in Istanbul (Intravenous morphine patient control device, External oblique
Recruiting
- Obesity
- +2 more
- Intravenous morphine patient control device
- External oblique intercostal plane block
-
Istanbul, TurkeyIstinye University Hospital
Jan 6, 2023
Music, Pain, Anxiety Trial in Singapore (Music listening)
Active, not recruiting
- Music
- +4 more
- Music listening
-
Singapore, SingaporeKK Women's and Children's Hospital
Mar 8, 2022
Anesthesia, Regional Anesthesia, Postoperative Pain Trial in Samsun (Bilateral ultrasound guided external oblique intercostal
Recruiting
- Anesthesia
- +2 more
- Bilateral ultrasound guided external oblique intercostal block (EOIB)
- +2 more
-
Samsun, Atakum, TurkeyOndokuz Mayis University
Jul 12, 2023
Cesarean Section Trial in Hangzhou (PCIA +Acupuncture group:)
Completed
- Cesarean Section
- PCIA +Acupuncture group:
-
Hangzhou, Zhejiang, China2nd Affiliated Hospital, School of Medicine, Zhejiang University
Sep 17, 2022